Roche Launches COVID PCR Test to Detect XBB.1.5 Omicron Sub-Variant
Roche and its subsidiary TIB Molbiol developed a COVID PCR test that detects and differentiates the latest variant of concern, XBB.1.5.
Read MorePosted by Andy Lundin | Feb 1, 2023 | Covid 19 |
Roche and its subsidiary TIB Molbiol developed a COVID PCR test that detects and differentiates the latest variant of concern, XBB.1.5.
Read MorePosted by Andy Lundin | Jan 31, 2023 | Diagnostic Technologies |
Arima Genomics announced an agreement with Protean BioDiagnostics to make its next-generation sequencing-based test available to clinicians.
Read MorePosted by Andy Lundin | Jan 30, 2023 | Covid 19 |
New machine learning research provides a way to predict if respiratory symptoms are caused by COVID, influenza, or RSV.
Read MorePosted by Andy Lundin | Jan 27, 2023 | Cancer |
VieCure is collaborating with Labcorp to provide clinicians with greater access to precision oncology decision support.
Read MorePosted by Andy Lundin | Jan 27, 2023 | Covid 19, Flu & Respiratory Infections |
Nomi Health is expanding its testing offerings to include influenzas A and B at its Utah COVID-19 testing sites.
Read More